期刊文献+

大肠癌的药物治疗 被引量:5

Drug therapy of colorectal cancer
暂未订购
导出
摘要 大肠癌作为消化道常见的恶性肿瘤,严重威胁着人类的健康。随着医学的不断进步,目前针对大肠癌治疗也逐渐向多元化发展。除手术治疗外的多种药物治疗在大肠癌的治疗中发挥重要的作用。本文将对大肠癌的化疗、免疫治疗、生物治疗、基因治疗、靶向治疗、中医中药治疗及对症支持治疗的研究逐一论述。 Colorectal cancer as the common malignant tumor in digestive tract is seriously threatening the health of human beings.With the development of medicine,current treatment for colorectal cancer has gradually diversified.In addition to surgical treatment,the multi-type drug therapy plays an important role in the treatment of colorectal cancer.This article reviews the effect of multi-type drug therapy for colorectal cancer,including chemotherapy,immunotherapy,biological therapy,gene therapy,targeted therapy,Chinese medicine treatment and supporting treatment.
作者 肖冰 王媛媛
出处 《胃肠病学和肝病学杂志》 CAS 2011年第3期206-211,共6页 Chinese Journal of Gastroenterology and Hepatology
关键词 大肠癌 药物治疗 Drug therapy Colorectal cancer
  • 相关文献

参考文献12

  • 1Saridaki Z, Tzardi M, Papadaki C, et al. Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in ≥2 line cetuximab-based therapy of eolorectal cancer patients [ J ]. PLoS One, 2011, 6(1): e15980.
  • 2张青,王笑民,杨国旺,胡凤山,赵文硕,唐武军,徐咏梅,富琦,唐勇,杨中,于洁,韩冬,罗晓琴,许金,张萃.固本消瘤胶囊联合FOLFOX4化疗方案治疗晚期大肠癌的临床研究[J].北京中医药,2010,29(4):255-257. 被引量:14
  • 3Koehne C, Bajetta E, Lin E, et al. Results of an interim analysis of a multinational randomized, double-blind, phase Ⅲ study in patients with previously treated metastatic colorectal cancer (MCRC) receiving FOLFOX4 and PTK787/ZK 222584 (PTK/ZK) or placebo (CON-FIRM2) (abst) [J]. Proc Am Soc Clin Oncol, 2006, 24:18s.
  • 4Nair SK, Morse M, Boczkowski D, et al. Induction of tumor-specific cytotoxie T-lymphoeytes in cancer patients by autologous tumor RNA- transfected dendritic cells [ J ]. Ann Surg, 2002, 235 (4) : 540-549.
  • 5Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. Version 1. 0. IARC Cancer Base No. 5. Lynn: 1ARC 2001.
  • 6Shi W, Teschendorf C, Muzyczka N, et al. Adeno-associated virusmediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo [J]. Cancer Gene Ther, 2002, 9(6): 513-521.
  • 7Nakano M, Aoki K, Matsumoto N, et al. Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA [J]. MolTher, 2001, 3(4): 491-499.
  • 8Tabernero J. The role of VEGF and EGFR inhibition:implications for combining anti-VEGF and anti-EGFR agents [ J ]. Mol Cancer Res, 2007, 5 ( 3 ) : 203-220.
  • 9沈琳.胃肠道肿瘤化疗及靶向药物治疗对病理学发展的需求[J].中华病理学杂志,2007,36(7):438-439. 被引量:11
  • 10Suzanne Kosmider,Lara Lipton.Adjuvant therapies for colorectal cancer[J].World Journal of Gastroenterology,2007,13(28):3799-3805. 被引量:8

二级参考文献72

共引文献58

同被引文献49

引证文献5

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部